NCT02167594View on ClinicalTrials.gov

Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

July 11, 2016

Study Completion Date

July 11, 2016

Conditions
Progressive Supranuclear PalsyCorticobasal Degeneration
Interventions
DRUG

Flortaucipir F18

IV injection, 370 megabecquerel (MBq) (10 mCi)

PROCEDURE

Brain PET scan

positron emission tomography (PET) scan of the brain 75-105 minutes post-injection

Trial Locations (5)

19104

Perelman School of Medicine, Philadelphia

35294

University of Alabama at Birmingham, Birmingham

92037

UCSD Movement Disorder Clinic, La Jolla

94158

UCSF Neurosciences Clinical Research Unit, San Francisco

06510

Molecular Neuroimaging, New Haven

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY